Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
THNR
THNR
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
THNR News
Hims & Hers, Eli Lilly, and Novo Nordisk Under FDA Review: Implications for Weight-Loss ETFs
Sep 18 2025
Benzinga
NVO Receives FDA Approval for MASH Therapy: ETFs Expected to Benefit
Aug 19 2025
NASDAQ.COM
Amplify ETFs Achieves Landmark $10 Billion in Assets Under Management
Jan 15 2025
Globenewswire
Eli Lilly Stock Soars 34.42% YTD: A $1000 Investment Outpaces Returns From These ETFs Holding Mounjaro-Maker Shares
Dec 13 2024
Benzinga
The Zacks Analyst Blog Highlights Eli Lilly, Novo Nordisk, PPH, HRTS and THNR
Oct 17 2024
NASDAQ.COM
Inside the Booming Obesity Drug Market: Weight Loss ETFs to Win
Oct 16 2024
NASDAQ.COM
Tap the Weight-Loss Drug Market With These ETFs
Sep 18 2024
NASDAQ.COM
5 ETFs to Make the Most of Eli Lilly's Strength
Aug 12 2024
NASDAQ.COM
EXCLUSIVE: Weight-Loss Duopoly Breaks As Eli Lilly, Novo Plummet; 'Market Won't Be Dominated By Just 2 Players'
Jul 18 2024
Benzinga
Can Eli Lilly ETFs Surge on Approval of Alzheimer's Drug?
Jun 19 2024
NASDAQ.COM
ETFs Bet High On Weight Loss Drugs, But Industry Observers Question Long-Term Potential
Jun 07 2024
Benzinga
ETFs to Profit from the Weight Loss Drug Boom
Jun 04 2024
NASDAQ.COM
What copper ETF investors need to know before chasing the commodity rally
May 23 2024
MarketWatch
Why Investors Haven't Feasted on Two New Weight-Loss ETFs
Jun 24 2024
investopedia.com
Show More News
